Center for Urogynecology & Pelvic Reconstructive Surgery, Subspecialty Care for Women's Health, Center for LGBT+ Care, Cleveland Clinic (Drs. Ferrando and Chapman).
Center for Urogynecology & Pelvic Reconstructive Surgery, Subspecialty Care for Women's Health, Center for LGBT+ Care, Cleveland Clinic (Drs. Ferrando and Chapman).
J Minim Invasive Gynecol. 2021 Sep;28(9):1579-1584. doi: 10.1016/j.jmig.2021.01.018. Epub 2021 Jan 23.
To describe the incidence of pelvic pain in transgender men undergoing hysterectomy for gender affirmation and to describe the incidence of endometriosis found at the time of surgery.
Retrospective chart review of transgender men presenting for gender-affirming hysterectomy between 2010 and 2019. Patients were identified by Current Procedural Terminology codes and documented male gender in the medical record, which was queried for perioperative data.
All patients underwent minimally invasive hysterectomy under general anesthesia by 2 surgeons at 2 institutions.
Patients were individuals assigned female at birth identifying as male who met the criteria for gender-affirming hysterectomy.
Hysterectomy performed using preferred techniques by the surgeons in this study.
Sixty-seven (N = 67) patients underwent hysterectomy: 98.5% (66) total laparoscopic with salpingo-oophorectomy and 1.5% (1) total laparoscopic with ovarian preservation. Mean age and body mass index were 29(±8) years and 28.6(±6.7) kg/m, respectively. Of the patients, 89.5% (60) were on testosterone for a median of 36 (12-300) months: 59.7% (40) were amenorrheic, 43.2% (29) had dysmenorrhea, 17.9% (12) reported heavy menses, and 14.9% had irregular menses. Furthermore, 50.7% (34) complained of pelvic pain (35.3% constant, 64.7% cyclic). Intraoperative endometriosis was diagnosed in 26.9% (18) of the patients: in 32.3% of the patients who reported pelvic pain and in 21.9% of the patients without pain. There were no differences between patients with endometriosis compared with those without endometriosis except for those with endometriosis were more likely to report irregular bleeding (27.8% vs 8.3%, p = .04) and were also more likely to complain of heavy menses (66.7% vs 35.4%, p = .03).
Of the transgender men who presented for hysterectomy, 50% reported pelvic pain, but only 1 in 3 with pain had findings of endometriosis. Patients found to have endometriosis were more likely to report irregular bleeding and/or heavy menses.
描述接受性别肯定性子宫切除术的跨性别男性的盆腔疼痛发生率,并描述手术时发现的子宫内膜异位症的发生率。
对 2010 年至 2019 年间接受性别肯定性子宫切除术的跨性别男性进行回顾性图表审查。通过当前程序术语 (CPT) 代码识别患者,并在病历中记录男性性别,对该性别进行围手术期数据查询。
所有患者均在 2 家机构的 2 名外科医生的全麻下接受微创手术性子宫切除术。
符合性别肯定性子宫切除术标准的出生时被认定为女性的个体,自认为是男性。
由本研究中的外科医生采用首选技术进行子宫切除术。
67 名患者(N=67)接受了子宫切除术:98.5%(66)全腹腔镜伴输卵管卵巢切除术和 1.5%(1)全腹腔镜伴卵巢保留。平均年龄和体重指数分别为 29(±8)岁和 28.6(±6.7)kg/m。患者中,89.5%(60)接受睾酮治疗,中位数为 36(12-300)个月:59.7%(40)闭经,43.2%(29)痛经,17.9%(12)经血量多,14.9%月经不规则。此外,50.7%(34)有盆腔疼痛(35.3%持续,64.7%周期性)。术中诊断为子宫内膜异位症的患者占 26.9%(18):报告盆腔疼痛的患者中占 32.3%,无疼痛的患者中占 21.9%。子宫内膜异位症患者与无子宫内膜异位症患者之间除子宫内膜异位症患者更有可能报告不规则出血(27.8%比 8.3%,p=0.04)和更有可能报告经血量多(66.7%比 35.4%,p=0.03)外,无其他差异。
在接受子宫切除术的跨性别男性中,有 50%报告有盆腔疼痛,但只有 1/3 的疼痛患者有子宫内膜异位症的发现。发现有子宫内膜异位症的患者更有可能报告不规则出血和/或经血量多。